Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity

Retina

Volumn 26, Issue 7, 2006, Pages 736-740

  Lakhanpal, Rohit R ^a   Fortun, Jorge A ^a   Chan Kai, Brian ^a   Holz, Eric R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Retinopathy of prematurity; Triamcinolone acetonide; Vascular endothelial growth factor

Indexed keywords

TRIAMCINOLONE ACETONIDE; VASCULOTROPIN;

ANATOMY; CLINICAL ARTICLE; DISEASE CLASSIFICATION; EYE BLOOD FLOW; FEMALE; FOLLOW UP; HUMAN; INFANT; INSTRUMENT; INTRAOCULAR PRESSURE; LENSECTOMY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PROGNOSIS; RETINA; RETINA DETACHMENT; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; REVIEW; VITRECTOMY;

BIRTH WEIGHT; COMBINED MODALITY THERAPY; FEMALE; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INJECTIONS; LENS, CRYSTALLINE; MALE; RETINAL DETACHMENT; RETINAL NEOVASCULARIZATION; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VITRECTOMY; VITREOUS BODY;

EID: 33748675309     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iae.0000244257.60524.89     Document Type: Review

References (25)

1. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-1134.
2. Gibson DL, Sheps SB, Uh SH, et al. Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics 1990;86:405-412.
3. Trese MT. Surgical results of stage V retrolental fibroplasia and timing of surgical repair. Ophthalmology 1984;91:461-466.
4. Trese MT. Visual results and prognostic factors for vision following surgery for stage V retinopathy of prematurity. Ophthalmology 1986;93:574-579.
5. Chong LP, Machemer R, de Juan E. Vitrectomy for advanced stages of retinopathy of prematurity. Am J Ophthalmol 1986;102:710-716.
6. Jabbour NM, Eller AE, Hirose T, et al. Stage 5 retinopathy of prematurity. Prognostic value of morphologic findings. Ophthalmology 1987;94:1640-1646.
7. Greven C, Tasman W. Scleral buckling in stages 4B and 5 retinopathy of prematurity. Ophthalmology 1990;97:817-820.
8. Zilis JD, deJuan E, Machemer R. Advanced retinopathy of prematurity. The anatomic and visual results of vitreous surgery. Ophthalmology 1990;97:821-826.
9. Maguire AM, Trese MT. Lens-sparing vitreoretinal surgery in infants. Arch Ophthalmol 1992;110:284-286.
10. Maguire AM, Trese MT. Visual results of lens-sparing vitreoretinal surgery in infants. J Pediatr Ophthalmol Strabismus 1993;30:28-32.
11. Trese MT, Droste PJ. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity. Ophthalmology 1998;105:992-997.
12. Capone A Jr, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology 2001;108:2068-2070.
13. Moshfeghi AA, Banach MJ, Salam GA, Ferrone PJ. Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity. Arch Ophthalmol 2004;122:1816-1818.
14. Prenner JL, Capone A Jr, Trese MT. Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology 2004;111:2271-2273.
15. Hubbard GB III, Cherwick DH, Burian G. Lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Ophthalmology 2004;111:2274-2777.
16. Hartnett ME. Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity. Retina 2003;23:322-329.
17. Lakhanpal RR, Sun RL, Albini TA, Holz ER. Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity. Ophthalmology 2005;112:1569-1573.
18. Lakhanpal RR, Sun RL, Albini TA, Holz ER. Anatomical success rate after primary three-port lens-sparing vitrectomy in stage 5 retinopathy of prematurity. Retina 2006;26:724-728.
19. Penn JS, Rajaratnam VS, Collier RJ, Clark AF. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2001;42:283-290.
20. Rotschild T, Nandgaonkar BN, Yu K, Higgins RD. Dexamethasone reduces oxygen induced retinopathy in a mouse model. Pediatr Res 1999;46:94-100.
21. Kompella UB, Bandi N, Ayalasomayajula SP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci 2003;44:1192-1201.
22. Tawansy KA, Lakhanpal RR, deJuan E Jr. Intravitreal triamcinolone for severe ROP refractory to laser ablation: one year results. Invest Ophthalmol Vis Sci 2005;46:E-Abstract 3493.
23. Marques LA, Narayanan R, Luthra S, Kenney MC, Kuppermann BD. Toxicity of triamcinolone acetonide (Kenalog) and preservative-free triamcinolone acetonide on cultured human retinal pigment epithelial (ARPE-19) cells. Invest Ophthalmol Vis Sci 2005;46:E-Abstract 3029.
24. Sonoda KH, Sakamoto T, Enaida H, et al. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 2004;111:226-230.
25. Jonas JB, Degenring RF, Kreissig I, et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 2005;112:593-598.